Clinical Guidance Category

Present On Admission Exempt Codes

ICD-10-CM diagnosis codes exempt from POA reporting based on the official FY2026 CMS POA exempt list.

Linked Diagnostic CodesPage 271 of 384 (38,349 total)
  • T44.2X4DBillable

    Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter

  • T44.2X4SBillable

    Poisoning by ganglionic blocking drugs, undetermined, sequela

  • T44.2X5DBillable

    Adverse effect of ganglionic blocking drugs, subsequent encounter

  • T44.2X5SBillable

    Adverse effect of ganglionic blocking drugs, sequela

  • T44.2X6DBillable

    Underdosing of ganglionic blocking drugs, subsequent encounter

  • T44.2X6SBillable

    Underdosing of ganglionic blocking drugs, sequela

  • T44.3X1DBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter

  • T44.3X1SBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela

  • T44.3X2DBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter

  • T44.3X2SBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela

  • T44.3X3DBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter

  • T44.3X3SBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela

  • T44.3X4DBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter

  • T44.3X4SBillable

    Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela

  • T44.3X5DBillable

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

  • T44.3X5SBillable

    Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

  • T44.3X6DBillable

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter

  • T44.3X6SBillable

    Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela

  • T44.4X1DBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

  • T44.4X1SBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela

  • T44.4X2DBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter

  • T44.4X2SBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela

  • T44.4X3DBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter

  • T44.4X3SBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela

  • T44.4X4DBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter

  • T44.4X4SBillable

    Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela

  • T44.4X5DBillable

    Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter

  • T44.4X5SBillable

    Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela

  • T44.4X6DBillable

    Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter

  • T44.4X6SBillable

    Underdosing of predominantly alpha-adrenoreceptor agonists, sequela

  • T44.5X1DBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter

  • T44.5X1SBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela

  • T44.5X2DBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter

  • T44.5X2SBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela

  • T44.5X3DBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter

  • T44.5X3SBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela

  • T44.5X4DBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter

  • T44.5X4SBillable

    Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela

  • T44.5X5DBillable

    Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter

  • T44.5X5SBillable

    Adverse effect of predominantly beta-adrenoreceptor agonists, sequela

  • T44.5X6DBillable

    Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter

  • T44.5X6SBillable

    Underdosing of predominantly beta-adrenoreceptor agonists, sequela

  • T44.6X1DBillable

    Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter

  • T44.6X1SBillable

    Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela

  • T44.6X2DBillable

    Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter

  • T44.6X2SBillable

    Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela

  • T44.6X3DBillable

    Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter

  • T44.6X3SBillable

    Poisoning by alpha-adrenoreceptor antagonists, assault, sequela

  • T44.6X4DBillable

    Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter

  • T44.6X4SBillable

    Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela

  • T44.6X5DBillable

    Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter

  • T44.6X5SBillable

    Adverse effect of alpha-adrenoreceptor antagonists, sequela

  • T44.6X6DBillable

    Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter

  • T44.6X6SBillable

    Underdosing of alpha-adrenoreceptor antagonists, sequela

  • T44.7X1DBillable

    Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter

  • T44.7X1SBillable

    Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela

  • T44.7X2DBillable

    Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter

  • T44.7X2SBillable

    Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela

  • T44.7X3DBillable

    Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter

  • T44.7X3SBillable

    Poisoning by beta-adrenoreceptor antagonists, assault, sequela

  • T44.7X4DBillable

    Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter

  • T44.7X4SBillable

    Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela

  • T44.7X5DBillable

    Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter

  • T44.7X5SBillable

    Adverse effect of beta-adrenoreceptor antagonists, sequela

  • T44.7X6DBillable

    Underdosing of beta-adrenoreceptor antagonists, subsequent encounter

  • T44.7X6SBillable

    Underdosing of beta-adrenoreceptor antagonists, sequela

  • T44.8X1DBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter

  • T44.8X1SBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela

  • T44.8X2DBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter

  • T44.8X2SBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela

  • T44.8X3DBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter

  • T44.8X3SBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela

  • T44.8X4DBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter

  • T44.8X4SBillable

    Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela

  • T44.8X5DBillable

    Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter

  • T44.8X5SBillable

    Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela

  • T44.8X6DBillable

    Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter

  • T44.8X6SBillable

    Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela

  • T44.901DBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter

  • T44.901SBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela

  • T44.902DBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter

  • T44.902SBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela

  • T44.903DBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter

  • T44.903SBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela

  • T44.904DBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter

  • T44.904SBillable

    Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela

  • T44.905DBillable

    Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter

  • T44.905SBillable

    Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela

  • T44.906DBillable

    Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter

  • T44.906SBillable

    Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela

  • T44.991DBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter

  • T44.991SBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela

  • T44.992DBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter

  • T44.992SBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela

  • T44.993DBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter

  • T44.993SBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, assault, sequela

  • T44.994DBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter

  • T44.994SBillable

    Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela

  • T44.995DBillable

    Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter

  • T44.995SBillable

    Adverse effect of other drug primarily affecting the autonomic nervous system, sequela